Overview
Uniparental disomy of chromosome 11 (UPD 11) is an obsolete Orphanet entry that previously referred to a chromosomal anomaly in which both copies of chromosome 11 (or a segment of it) are inherited from a single parent rather than one from each parent. This concept is not itself a standalone disease but rather a genetic mechanism that can underlie specific clinical conditions depending on which parent contributes both copies and which chromosomal region is involved. The most clinically significant form is paternal uniparental disomy of chromosome 11p15, which is a well-recognized cause of Beckwith-Wiedemann syndrome (BWS), characterized by overgrowth, macroglossia (enlarged tongue), abdominal wall defects (such as omphalocele), organomegaly, neonatal hypoglycemia, and an increased risk of embryonal tumors including Wilms tumor and hepatoblastoma. Maternal UPD of chromosome 11 has been associated with features overlapping with Silver-Russell syndrome, including intrauterine and postnatal growth restriction. Because this Orphanet entry (263034) is designated as obsolete, patients and clinicians are directed to the specific syndrome entries — primarily Beckwith-Wiedemann syndrome (Orphanet: 116) for paternal UPD 11p15 or Silver-Russell syndrome (Orphanet: 813) for maternal UPD 11 — for current clinical guidance. The affected body systems vary depending on the resulting phenotype but commonly include the musculoskeletal system, endocrine system, kidneys, liver, and abdominal organs. Management is syndrome-specific and may include monitoring blood glucose in the neonatal period, surgical correction of abdominal wall defects, tumor surveillance protocols (particularly for Wilms tumor and hepatoblastoma in BWS), and growth support in cases of growth restriction. Genetic counseling is recommended for affected families, as the recurrence risk depends on the underlying mechanism of UPD.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Uniparental disomy of chromosome 11.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Uniparental disomy of chromosome 11 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Uniparental disomy of chromosome 11.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Uniparental disomy of chromosome 11.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Uniparental disomy of chromosome 11.
Start the conversation →Latest news about OBSOLETE: Uniparental disomy of chromosome 11
No recent news articles for OBSOLETE: Uniparental disomy of chromosome 11.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Uniparental disomy of chromosome 11
What is OBSOLETE: Uniparental disomy of chromosome 11?
Uniparental disomy of chromosome 11 (UPD 11) is an obsolete Orphanet entry that previously referred to a chromosomal anomaly in which both copies of chromosome 11 (or a segment of it) are inherited from a single parent rather than one from each parent. This concept is not itself a standalone disease but rather a genetic mechanism that can underlie specific clinical conditions depending on which parent contributes both copies and which chromosomal region is involved. The most clinically significant form is paternal uniparental disomy of chromosome 11p15, which is a well-recognized cause of Beck
How is OBSOLETE: Uniparental disomy of chromosome 11 inherited?
OBSOLETE: Uniparental disomy of chromosome 11 follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Uniparental disomy of chromosome 11 typically begin?
Typical onset of OBSOLETE: Uniparental disomy of chromosome 11 is neonatal. Age of onset can vary across affected individuals.